The subjective quality of life of young patients with breast cancer and their partners.

Authors

null

Laurence Vanlemmens

Centre Oscar Lambret, Lille, France

Laurence Vanlemmens , Veronique Christophe , Christelle Duprez , Anne Congard , Anne Lesur , Catherine Loustalot , Cecile Guillemet , Monelle Leclercq , Pascal Antoine

Organizations

Centre Oscar Lambret, Lille, France, University Lille Nord de France - Université de Lille 3, Villeneuve d'Ascq, France, Université Lille 3, Lille, France, Université de Provence, Aix-en-Provence, France, Institut de Cancérologie de Lorraine, Vandœuvre-les- Nancy, France, Department of Surgery/Georges François Leclerc Comprehensive Cancer Care Centre, Dijon, France, Centre Henri Becquerel, Rouen, France, College of Gynecologist, Marcq en Baroeul, France, Université de Lille 3, Lille, France

Research Funding

No funding sources reported

Background: The subjective experience of young breast cancer (BC) women has some specifics related to the impact of illness and treatments on the issues specific to their age. The partner is most often the primary caregiver and is himself affected by the disease. A better understanding of couples facing cancer at every stage of treatment program appears crucial to improve the overall care. This study aims to better understand the quality of life of these young couples (women <45 at diagnosis), by comparing the subjective experience of patients and partners from chemotherapy (CT) to the end of treatments period. Methods: 491 couples in which the woman has non-metastatic BC (28.7% under CT, 10.2% under Trastuzumab, 33% under hormone therapy, 28.1% under supervision) completed a self-administered questionnaire assessing their subjective experience. Results: Patients report more difficulties than partners in terms of management of children and of everyday life, body image and sexuality, career management and financial difficulties. The 2 groups were comparable with regard to the feeling of couple cohesion and the deterioration of relations with relatives. In addition, patients reported more support from relatives than partners, but this support decreases along the treatment program. While overall, patients undergoing CT and Trastuzumab and their partners reported more difficulties than those under hormone therapy or under surveillance, the negative affectivity / apprehension for the futureremains stable and relatively high from CT to the end of treatment, for the patient as well as for her partner. Conclusions: The difficulties of patients appear to be particularly strong in the early course of care and decrease over time, indicating a gradual adjustment to the disease. It is the same for partners, who also have concerns. However, there are differences between the experience of patients and partners. A longitudinal follow-up assessing the couple experience in a dyadic design would allow us to support these findings, and ultimately to better assess the couples’ needs in order to better respond to it by an optimal care management, including the establishment of follow-up consultations for couples.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Psychosocial and Communication Research

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 9569)

DOI

10.1200/jco.2014.32.15_suppl.9569

Abstract #

9569

Poster Bd #

219

Abstract Disclosures